|CRDAMC Homepage | CRDAMC Library Phone #: (254) 288-8366 | CRDAMC Library Fax #: (254) 288-8368|
March 28, 2017
What You Need to Know About Cholesterol
MONDAY, March 27, 2017 (HealthDay News) -- Cholesterol plays a vital role in your health, so it's important to understand the different types of cholesterol and how to influence their levels, a heart specialist says.
Health Tip: Ease Varicose Veins
(HealthDay News) -- Varicose veins are swollen, bulging blood vessels that usually form in the legs. And while you may not be able to prevent them, you may be able to stop them from getting worse.
Health Tip: Talk to Your Doctor About Emotional Struggles
(HealthDay News) -- Your emotional health can impact your physical health, and your doctor can help you find healthier ways to deal with emotional challenges.
Study: Plenty of IV Fluids May Make Childbirth Safer, Easier
MONDAY, March 27, 2017 (HealthDay News) -- Giving more intravenous (IV) fluids to women during childbirth seems to reduce the risk of cesarean section and shortens labor, researchers report.
Exercise: The Cellular 'Fountain of Youth'
TUESDAY, March 28, 2017 (HealthDay News) -- High-intensity exercise may help older adults reverse certain aspects of the "cellular" aging process, a new study suggests.
Lead Exposure as Child, Lower IQ as Adult?
TUESDAY, March 28, 2017 (HealthDay News) -- Adults who had high levels of lead exposure during childhood may have lower IQs and poorer-paying jobs as adults, a new study suggests.
Brain-Computer Link Restores Some Movement to Quadraplegic Man
TUESDAY, March 28, 2017 (HealthDay News) -- Grabbing a mug of coffee, having a sip.
Many Women Who Get Breast Cancer Gene Test Don't Need It
TUESDAY, March 28, 2017 (HealthDay News) -- An increasing number of American women who don't have breast or ovarian cancer are being tested for BRCA and BRCA2 gene mutations associated with those diseases, a new study shows.
Knee Replacement Doesn't Always Pay, Researchers Say
TUESDAY, March 28, 2017 (HealthDay News) -- Knee replacement surgery isn't always a game changer, according to a new study that raises questions about the increasingly common procedure.
Health Highlights: March 28, 2017
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Better Efforts Could Help Rid the U.S. of Hepatitis B, C: Report
TUESDAY, March 28, 2017 (HealthDay News) -- Improved prevention, screening and treatment could help eliminate hepatitis B and C as serious public health problems in the United States and save nearly 90,000 lives by 2030, according to a new report.
More Older Women Hitting the Bottle Hard
TUESDAY, March 28, 2017 (HealthDay News) -- More older American women than ever are drinking -- and drinking hard, a new study shows.
Health Insurance a Key to IVF Success, Researchers Say
TUESDAY, March 28, 2017 (HealthDay News) -- Having health insurance that covers in vitro fertilization (IVF) boosts the odds the treatment will lead to childbirth, a new study finds.
High Doses of Vitamin D Fail to Cut Cancer Risk, Study Finds
TUESDAY, March 28, 2017 (HealthDay News) -- High doses of vitamin D supplements may not lower older women's risk of developing cancer, a new clinical trial finds.
Kids Peppered With Pot Ads
TUESDAY, March 28, 2017 (HealthDay News) -- There has been an alarming increase in young Americans' exposure to marijuana ads as more states legalize the drug, a new study contends.
Marathon Running May Cause Short-Term Kidney Injury
TUESDAY, March 28, 2017 (HealthDay News) -- Any marathoner will tell you that the grueling 26-mile races can do a number on the hips, knees, ankles and feet.
Zejula Approved for Certain Female Cancers
TUESDAY, March 28, 2017 (HealthDay News) -- Zejula (niraparib) has been approved by the U.S. Food and Drug Administration to treat adult women with recurring cancers of the ovaries, fallopian tubes or abdominal wall (peritoneum) whose tumors have shrunk in response to platinum-based chemotherapy.
New Eczema Drug Gets FDA's Blessing
TUESDAY, March 28, 2017 (HealthDay News) -- Adults plagued by eczema may have a new treatment option, with a new drug approved Tuesday by the U.S. Food and Drug Administration.
Dupixent Approved to Treat Eczema
TUESDAY, March 28, 2017 (HealthDay News) -- Dupixent (dupilumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe eczema that isn't well controlled by topical medication.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at email@example.com. Our Health Library Support team will respond to your email request within 2 business days.